Open Access Article
Luka A.
Wright
a,
Eric G.
Hope
a,
Gregory A.
Solan
*a,
Warren B.
Cross
ab and
Kuldip
Singh
a
aDepartment of Chemistry, University of Leicester, University Road, Leicester LE1 7RH, UK. E-mail: gas8@leicester.ac.uk
bSchool of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS, UK
First published on 9th March 2015
The 2-(2′-aniline)-6-imine-pyridines, 2-(C6H4-2′-NH2)-6-(CMe
NAr)C5H3N (Ar = 4-i-PrC6H4 (HL1a), 2,6-i-Pr2C6H3 (HL1b)), have been synthesised via sequential Stille cross-coupling, deprotection and condensation steps from 6-tributylstannyl-2-(2-methyl-1,3-dioxolan-2-yl)pyridine and 2-bromonitrobenzene. The palladium(II) acetate N,N,N-pincer complexes, [{2-(C6H4-2′-NH)-6-(CMe
NAr)C5H3N}Pd(OAc)] (Ar = 4-i-PrC6H4 (1a), 2,6-i-Pr2C6H3 (1b)), can be prepared by reacting HL1 with Pd(OAc)2 or, in the case of 1a, more conveniently by the template reaction of ketone 2-(C6H4-2′-NH2)-6-(CMe
O)C5H3N, Pd(OAc)2 and 4-isopropylaniline; ready conversion of 1 to their chloride analogues, [{2-(C6H4-2′-NH)-6-(CMe
NAr)C5H3N}PdCl] (Ar = 4-i-PrC6H4 (2a), 2,6-i-Pr2C6H3 (2b)), has been demonstrated. The phenyl-containing complexes, [{2-(C6H4-2′-NH)-6-(CMe
NAr)C5H3N}PdPh] (Ar = 4-i-PrC6H4 (3a), 2,6-i-Pr2C6H3 (3b)), can be obtained by treating HL1 with (PPh3)2PdPh(Br) in the presence of NaH or with regard to 3a, by the salt elimination reaction of 2a with phenyllithium. Reaction of 2a with silver tetrafluoroborate or triflate in the presence of acetonitrile allows access to cationic [{2-(C6H4-2′-NH)-6-(CMe
N(4-i-PrC6H4)C5H3N}Pd(NCMe)][X] (X = BF4 (4), X = O3SCF3 (5)), respectively; the pyridine analogue of 5, [{2-(C6H4-2′-NH)-6-(CMe
N(4-i-PrC6H4)C5H3N}Pd(NC5H5)][O3SCF3] (5′), is also reported. Oxidation of phenyl-containing 3a with one equivalent of 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) (Selectfluor™) in acetonitrile at low temperature leads to a new palladium species that slowly decomposes to give 4 and biphenyl; biphenyl formation is also observed upon reaction of 3a with XeF2. However, no such oxidatively induced coupling occurs when using 3b. Single crystal X-ray diffraction studies have been performed on HL1b, 1a, 1b, 2a, 2b, 3a, 3b and 5′.
Given the apparent variation in coupling events that can occur from a high valent organo-Pd species,1–7 we have been interested in exploring the influence of a supporting multidentate ligand on the oxidatively induced reaction pathway. Herein, we report the reactivity of a family of N,N,N-pincer bearing Pd(II) mono-phenyl complexes of the type, [{2-(C6H4-2-NH)-6-(CMe
NAr)C5H3N}PdPh] (Ar = aryl (3)), towards Selectfluor and XeF2 (Fig. 1);10 as an additional point of interest the effects that steric variation (Ar = 4-i-PrC6H4, 2,6-i-Pr2C6H3) has on the reactivity, will be investigated. Furthermore, we report the full synthetic details for the preparation of the novel pro-ligands (HL1) and their palladium(II) acetate (1), chloride (2) and phenyl (3) derivatives.
NAr)C5H3N (Ar = 4-i-PrC6H4 (HL1a), 2,6-i-Pr2C6H3 (HL1b)), have been prepared in reasonable yield via sequential Stille coupling, deprotection and condensation reactions from 6-tributylstannyl-2-(2-methyl-1,3-dioxolan-2-yl)pyridine and 2-bromonitrobenzene (Scheme 1). For both HL1a and HL1b, the condensation step proved sluggish in alcoholic media but proceeded more effectively by running the reaction in the neat aniline at high temperature; nevertheless problems encountered in the work-up of HL1a resulted in its isolation in only a modest yield (see later for a higher yielding template approach to L1a). The precursor ketone and the two N,N,N pro-ligands, HL1a and HL1b, have been characterised using a combination of electrospray mass spectrometry, IR, 1H NMR and 13C NMR spectroscopy (see Experimental section).
![]() | ||
| Scheme 1 Reagents and conditions: (i) 2-BrC6H4NO2, cat. Pd(OAc)2–PPh3, toluene, 100 °C, microwave; (ii) SnCl2, ethanol; (iii) HCl(aq.); (iv) ArNH2, 225 °C. | ||
Compounds, HL1a, and HL1b, both display protonated molecular ions peaks in their electrospray mass spectra and downfield shifted signals for the amino protons (range: δ 5.72–5.79) in their 1H NMR spectra. Characteristic imine stretching frequencies of ca. 1638 cm−1 are seen in their IR spectra as are higher wavenumber bands corresponding to the N–H stretches. Further confirmation of the composition of HL1b was achieved in the form of a single crystal X-ray determination.
A perspective view of HL1b is depicted in Fig. 2; selected bond distances and angles are listed in Table 1. The structure consists of a central pyridine ring that is substituted at its 2-position by a phenyl-2′-amine group and at the 6-position by a trans-configured N-arylimine unit [C(7)–N(1) 1.277(3) Å]. The pyridine nitrogen atoms adopt a cis conformation with respect to the neighbouring aniline nitrogen (tors: N(2)–C(13)–C(14)–C(15) 8.1°) as a result of a hydrogen-bonding interaction between one of the amino hydrogen atoms and the pyridine nitrogen [N(3)⋯N(2) 2.675 Å]; a similar arrangement has been reported for a related quinolinyl-substituted aniline.11
![]() | ||
| Fig. 2 Molecular structure of HL1b, including a partial atom numbering scheme. All hydrogen atoms, apart from H3A and H3B, have been omitted for clarity. | ||
| Bond lengths | |||
| C(15)–N(3) | 1.366(4) | C(13)–C(14) | 1.477(4) |
| C(7)–N(1) | 1.277(3) | C(7)–C(9) | 1.482(4) |
| C(7)–C(8) | 1.504(4) | ||
| Bond angles | |||
| C(8)–C(7)–N(1) | 125.3(2) | C(9)–C(7)–N(1) | 116.4(3) |
N(2,6-i-Pr2C6H3))C5H3N}Pd(OAc)] (1b)), in good yield (Scheme 2). While [{2-(C6H4-2-NH)-6-(CMe
N(4-i-PrC6H4))C5H3N}Pd(OAc)] (1a) could also be made by this route, it was more conveniently prepared by the template reaction of ketone 2-(C6H4-2-NH2)-6-(CMe
O)C5H3N, Pd(OAc)2 and 4-isopropylaniline. Compounds 1 can be readily converted to their chloride analogues, [{2-(C6H4-2-NH)-6-(CMe
NAr)C5H3N}PdCl] (Ar = 4-i-PrC6H4 (2a), 2,6-i-Pr2C6H3 (2b)), by treatment of a dichloromethane solution of 1 with aqueous sodium chloride. All four complexes are air stable and have been characterised using a combination of FAB mass spectrometry, IR and NMR (1H and 13C) spectroscopy and elemental analyses (see Experimental section). In addition, crystals of each complex have been the subject of single crystal X-ray diffraction studies.
Views of acetate-containing 1a and 1b are given in Fig. 3 and 4; selected bond distances and angles are collected for both structures in Table 2. There are two independent molecules for 1b in the unit cell (A and B) which differ most noticeably in the relative inclination of neighbouring pyridyl and anilido ring planes (vide infra). The structures of 1a and 1b are similar consisting of a four-coordinate palladium centre bound by a tridentate monoanionic 2-(2′-anilido)-6-imine-pyridine ligand and a monodentate O-bound acetate, but contrast in the nature of the hydrogen bonding involving the acetate ligand. In 1a, a water molecule present within the unit cell links the palladium-acetate units to form a hydrogen-bonded network [O(1)acetate⋯O(3)water 2.837, O(3)water⋯O(2A)acetate 2.877 Å], while in 1b the hydrogen bonding is intramolecular in origin involving the pendant acetate oxygen and the anilido proton [N(3)⋯O(2)acetate 2.799A, 2.889B Å]. Within the N,N,N-ligand there are both 5- and 6-membered chelate rings with the bite angle for the 6-membered ring being more compatible with the square planar geometrical requirements of the palladium(II) centre [N(3)–Pd(1)–N(2)6-membered: 93.7(2) (1a), 92.2(3)A, 93.6(2)B (1b) vs. N(2)–Pd(1)–N(1)5-membered 82.2(2) (1a), 82.6(3)A, 82.1(2)B° (1b)]. In both cases some twisting of the anilido unit with respect to the adjacent pyridyl plane is apparent [tors. N(2)–C(13)–C(14)–C(15) 3.6(4) (1a), 4.9(4)A, 9.0(5)B° (1b)]. For a given complex, the Pd–Nimine bond distance is the longest of the three metal–ligand interactions involving the N,N,N-ligand followed by the Pd–Npyridine distance and then by the Pd–Nanilido distance which is best exemplified for 1a [Pd(1)–N(1)imine 2.014(6) > Pd(1)–N(2)pyridine 1.963(5) > Pd(1)–N(3)anilido 1.932(5) Å]. The N-aryl groups are inclined towards orthogonality with regard to the neighbouring C
Nimine vector [tors. C(7)–N(1)–C(1)–C(6) 87.6(4) (1a), 86.4(4)av° (1b)], with the 2,6-diisopropyl substitution on the N-aryl group in 1b additionally providing some steric protection to the axial sites of the palladium centre. The closest crystallographically characterised comparators to 1 are the phenolate-containing counterparts, [{2-(C6H4-2′-O)-6-(CMe
NAr)C5H3N}Pd(OAc)] (Ar = 4-i-PrC6H4, 2,6-i-Pr2C6H3), which display similar bonding characteristics.12
![]() | ||
| Fig. 4 Molecular structure of 1b (molecule A) including a partial atom numbering scheme. All hydrogen atoms, apart from H3 have been omitted for clarity. | ||
| 1b | |||
|---|---|---|---|
| 1a | Molecule A | Molecule B | |
| Bond lengths | |||
| Pd(1)–N(1) | 2.014(6) | 2.017(8) | 2.019(8) |
| Pd(1)–N(2) | 1.963(5) | 1.970(9) | 1.977(7) |
| Pd(1)–N(3) | 1.932(5) | 1.920(9) | 1.922(8) |
| Pd(1)–O(1) | 2.036(5) | 2.011(8) | 2.021(7) |
| C(7)–N(1) | 1.286(8) | 1.285(12) | 1.300(11) |
| C(9)–C(7) | 1.469(9) | 1.468(13) | 1.458(13) |
| C(15)–N(3) | 1.347(9) | 1.316(12) | 1.323(12) |
| Bond angles | |||
| N(1)–Pd(1)–N(2) | 82.2(2) | 82.6(3) | 82.1(2) |
| N(1)–Pd(1)–N(3) | 174.6(3) | 174.3(3) | 174.4(2) |
| N(1)–Pd(1)–O(1) | 93.8(2) | 89.6(3) | 93.8(2) |
| N(2)–Pd(1)–N(3) | 93.7(2) | 92.2(3) | 93.6(2) |
| N(3)–Pd(1)–O(1) | 90.3(2) | 95.6(3) | 90.5(2) |
A view of chloride-containing 2b is given in Fig. 5; selected bond distances and angles are collected for both 2a and 2b in Table 3. The two independent molecules present in the unit cell for 2a (A and B) differ most noticeably in the inclination of the N-aryl plane to the adjacent imine unit. The structures of 2a and 2b are similar to those of their acetate precursors (1) with a tridentate monoanionic 2-(2′-anilido)-6-imine-pyridine filling three coordination sites of the distorted square planar geometry but differ with a chloride now filling the fourth site. Replacing a chloride for an O-bound acetate has little effect on the trans Pd–Npyridine distance [1.976(5)A, 1.984(5)B (2a), 1.987(3) (2b) vs. 1.963(5) (1a), 1.970(9)A 1.977(7)B Å (1b)]. Unlike 1b, the anilido NH proton is not involved in any inter- or intra-molecular contacts of note.
![]() | ||
| Fig. 5 Molecular structure of 2b including a partial atom numbering scheme. All hydrogen atoms, apart from H3, have been omitted for clarity. | ||
| 2a | 2b | ||
|---|---|---|---|
| Molecule A | Molecule B | ||
| Bond lengths | |||
| Pd(1)–N(1) | 2.022(5) | 2.035(6) | 2.025(3) |
| Pd(1)–N(2) | 1.976(5) | 1.984(5) | 1.987(3) |
| Pd(1)–N(3) | 1.934(5) | 1.931(6) | 1.927(3) |
| Pd(1)–Cl(1) | 2.2971(18) | 2.2931(18) | 2.3123(17) |
| C(7)–N(1) | 1.297(7) | 1.298(7) | 1.289(5) |
| C(15)–N(3) | 1.335(8) | 1.334(8) | 1.336(5) |
| Bond angles | |||
| N(1)–Pd(1)–N(2) | 81.6(2) | 82.2(3) | 82.01(13) |
| N(1)–Pd(1)–N(3) | 174.4(2) | 174.0(2) | 173.63(13) |
| N(2)–Pd(1)–N(3) | 93.1(2) | 92.2(3) | 91.91(13) |
| N(1)–Pd(1)–Cl(1) | 96.66(16) | 96.56(17) | 97.63(10) |
| N(2)–Pd(1)–Cl(1) | 178.21(17) | 175.39(15) | 179.27(9) |
| N(3)–Pd(1)–Cl(1) | 88.54(16) | 89.14(17) | 88.47(10) |
Complexes 1a, 1b, 2a and 2b, all display molecular ion peaks in their FAB mass spectra along with fragmentation peaks corresponding to the loss of an acetate or a chloride, respectively. In their IR spectra the imine stretching frequencies are shifted between 28 and 35 cm−1 to lower wavenumber in comparison with the corresponding free HL1, characteristic of imine-nitrogen coordination.13–15 In 1b and 2b two distinct doublets are seen for the isopropyl methyl groups in their 1H NMR spectra consistent with some restricted rotation about the N-2,6-diisopropylphenyl bond in solution. The acetate methyl groups in 1 can be seen at δ ca. 1.5 in their 1H NMR spectra with the MeC(O)O carbon atoms observable at δ ca. 177.1 in their 13C NMR spectra. The anilido NH proton in 2 is observable at a similar chemical shift (ca. δ 5.8) to that seen in free HL1, but in acetate-containing 1 there is some variation with that observed in 1b being more downfield (δ 5.60 (1a), 7.39 (1b)); this is likely to be due to the influence of the intramolecular NH⋯Oacetate hydrogen bonding seen in 1b (see Fig. 4). As with related monodentate acetate complexes, 1a and 1b both show strong bands assignable to the symmetric and asymmetric ν(COO) vibrations.16
Their phenyl derivatives, [{2-(C6H4-2-NH)-6-(CMe
NAr)C5H3N}PdPh] (Ar = 4-i-PrC6H4 (3a), 2,6-i-Pr2C6H3 (3b)), could be readily accessed by treatment of HL1 with NaH followed by (PPh3)2PdPh(Br) (Scheme 3). Alternatively, 3a can be prepared by treating chloride 2a with phenyl lithium; a related salt elimination approach to make 3b has not proved possible. In the case of 2a, chloride abstraction with both silver tetrafluoroborate and triflate in acetonitrile proved facile affording [{2-(C6H4-2′-NH)-6-(CMe
N(4-i-PrC6H4)C5H3N}Pd(NCMe)][X] (X = BF4 (4), X = O3SCF3 (5)) in high yield (Scheme 3). Mono-phenyl 3a and 3b are air and water stable, whereas 4 and 5 proved hygroscopic on prolonged standing. All four complexes have been characterised using a combination of FAB mass spectrometry, IR and NMR (1H and 13C) spectroscopy and elemental analyses (see Experimental section).
![]() | ||
| Scheme 3 Reagents and conditions: (i) xs. NaH, THF, heat; (ii) (PPh3)2PdPh(Br), THF, heat; (iii) LiPh, THF, −78 °C; (iv) AgX (X = BF4, O3SCF3), MeCN, RT. | ||
The mass spectra of 3a and 3b exhibit molecular ions while 4 and 5 display peaks corresponding to their cationic units. As with 1 and 2, all four complexes exhibit ν(C
N)imine stretches at lower wavenumber (typically by 35 cm−1) when compared with HL1, supporting coordination of L1 to the metal centre.13–15 The imine methyl resonances are seen between δ 2.2 and 2.5 in their 1H NMR spectra, while signals for the imine carbon fall between δ 170.5 and 174.8 in their 13C{1H} NMR spectra. Signals attributable to [BF4]− and [O3SCF3]− counterions could also be seen in the 19F NMR spectra of 4 and 5. In addition, crystals of 3a, 3b and the pyridine analogue of 5, [{2-(C6H4-2′-NH)-6-(CMe
N(4-i-PrC6H4)C5H3N}Pd(NC5H5)][O3SCF3] (5′), have been the subject of single crystal X-ray diffraction studies.
As a representative of the mono-phenyl pair of structures, a view of the molecular structure of 3a is depicted in Fig. 6; selected bond distances and angles are listed in Table 4 for both 3a and 3b. As with 1 and 2, 2-(2′-anilido)-6-imine-pyridine ligand acts a tridentate ligand with the σ-phenyl ligand now occupying the fourth coordination site to complete a distorted square planar geometry. The phenyl ligand in both structures is tilted with respect to the trans-pyridine unit of the N,N,N-ligand and most noticeably for 3a, presumably as a consequence of the variation in steric hindrance imposed by the N-aryl groups [tors. C(13)–N(2)–C(23)–C(24) 46.4(4) (3a), 41.4(4)° (3b)]. When compared to 1 and 2, the presence of a σ-phenyl group in 3 results in an elongation of the trans Pd–Npyridine distance [Pd–N(2) 2.066(6) (3a), 2.069(2) (3b) vs. 1.963(5) (1a), 1.974(8)av. (1b), 1.980(5)av. (2a), 1.987(3) (2b) Å], an observation attributable to the strong trans-influence exhibited by the aryl group. In contrast, the exterior nitrogen-palladium distances remain similar in length to those seen in 1 and 2. To accommodate the increased Pd–N(2)pyridine distance, there is increased twisting of the ligand backbone which is most apparent in 3b [tors. N(2)–C(13)–C(14)–C(15) 25.2(4) and N(1)–C(7)–C(9)–N(2) 13.7(4)°]. As with chloride-containing 2, the anilido NH proton shows no notable intra- or inter-molecular contacts of note.
![]() | ||
| Fig. 6 Molecular structure of 3a including a partial atom numbering scheme. All hydrogen atoms, apart from H3, have been omitted for clarity. | ||
| 3a | 3b | |
|---|---|---|
| Bond lengths | ||
| Pd(1)–N(1) | 2.060(6) | 2.041(2) |
| Pd(1)–N(2) | 2.066(6) | 2.069(2) |
| Pd(1)–N(3) | 1.937(6) | 1.959(3) |
| Pd(1)–C(23) | 2.016(8) | 2.013(3) |
| C(7)–N(1) | 1.302(9) | 1.291(4) |
| C(9)–C(7) | 1.452(10) | 1.472(4) |
| C(15)–N(3) | 1.326(9) | 1.348(4) |
| Bond angles | ||
| N(1)–Pd(1)–N(2) | 81.0(3) | 79.88(10) |
| N(1)–Pd(1)–N(3) | 172.5(3) | 171.38(10) |
| N(1)–Pd(1)–C(23) | 99.2(3) | 99.68(11) |
| N(2)–Pd(1)–C(23) | 178.5(3) | 169.73(11) |
| N(3)–Pd(1)–N(2) | 91.5(3) | 79.88(10) |
Unfortunately cationic 4 and 5 were not amenable to forming crystals suitable for an X-ray determination. To overcome this practical issue, small amounts of pyridine were added to a solution of 5 in chloroform and hexane slowly diffused forming single crystals of [{2-(C6H4-2′-NH)-6-(CMe
N(4-i-PrC6H4)C5H3N}Pd(NC5H5)][O3SCF3] (5′). The molecular structure of the cationic unit 5′ is depicted in Fig. 7; selected bond distances and angles are listed in Table 5. As with a number of the structures reported in this study, two independent molecules (A and B) were present in the unit cell which, in this case, differ most noticeably in the inclination of the N-aryl groups. The structure of 5′ consists of a palladium(II) cationic unit charge balanced by a non-coordinating triflate counteranion. Within the distorted square planar cationic unit, the 2-(2′-anilido)-6-imine-pyridine ligand acts a tridentate ligand and an N-bound pyridine fills the fourth coordination site. Similar to phenyl-bound 3, the monodentate heteroaromatic in 5′ is not co-planar with the trans-pyridine unit of the tridentate ligand. Instead it adopts a tilted configuration [C(13)–N(2)–N(4)–C(27) 58.1(5)A, 60.0(5)B°] which is ca. 8° greater than that for the aryl group in 3b. Inspection of the trans Pd–N(2)pyridine distance involving the N,N,N-ligand reveals a bond length [Pd(1)–N(2) 1.992(11)A, 1.952(11)B Å] comparable with those seen in 1 and 2, but shorter than that in 3 (vide supra). The NH proton of the anilido unit of the pincer undergoes a modest interaction with a triflate oxygen atom [N(3)⋯O(1) 3.096A, 3.175B Å].
![]() | ||
| Fig. 7 Molecular structure of cationic unit in 5′, including a partial atom numbering scheme. All hydrogen atoms, except for H3, have been omitted for clarity. | ||
| Molecule A | Molecule B | |
|---|---|---|
| Bond lengths | ||
| Pd(1)–N(1) | 2.049(12) | 2.034(12) |
| Pd(1)–N(2) | 1.992(11) | 1.952(11) |
| Pd(1)–N(3) | 1.937(11) | 1.962(11) |
| Pd(1)–N(4) | 2.010(11) | 2.105(11) |
| C(7)–N(1) | 1.276(16) | 1.279(16) |
| C(15)–N(3) | 1.336(15) | 1.316(16) |
| Range S–O (triflate) | 1.424(11)–1.485(10) | |
| Bond angles | ||
| N(1)–Pd(1)–N(2) | 82.9(5) | 82.0(5) |
| N(1)–Pd(1)–N(3) | 175.3(5) | 174.9(4) |
| N(1)–Pd(1)–N(4) | 93.7(5) | 94.0(5) |
| N(2)–Pd(1)–N(3) | 92.6(5) | 93.8(5) |
| N(2)–Pd(1)–N(4) | 176.6(5) | 175.7(5) |
| N(3)–Pd(1)–N(4) | 90.8(5) | 90.3(4) |
To investigate the reaction further and potentially observe any possible intermediates, a reaction involving an equimolar ratio of 3a and Selectfluor was undertaken in CD3CN at a series of lower temperatures and the reaction monitored by 1H and 19F NMR spectroscopy (Scheme 4). After 15 minutes at room temperature the 19F NMR spectrum revealed full consumption of Selectfluor and a new peak at δ −181 attributable to the formation of hydrogen fluoride.17 The 1H NMR spectrum contained signals consistent with biphenyl, the salt [{2-(C6H4-2-NH)-6-(CMe
N(4-i-PrC6H4)C5H3N}Pd(NCCD3)][BF4] (4) (vide supra) and 1-(chloromethyl)-1,4-diazabicyclo[2.2.2]octan-1-ium tetrafluoroborate, the Selectfluor degradation product. In addition, there were signals present attributable to another palladium species that slowly reduced in intensity over time.
When the reaction was carried out at −40 °C, full consumption of Selectfluor was again evident from the 19F NMR spectrum which also contained a peak attributable to HF, albeit temperature shifted (δ −172). In the 1H NMR spectrum full conversion of 3a to a single palladium species was observed with the aromatic/pyridyl region integrating to sixteen protons; no peaks assignable to biphenyl nor 4 could be identified. As the reaction mixture was warmed to 0 °C, only sharpening of the 1H NMR spectrum was observed with peaks that clearly match those observed for the decomposing palladium species seen at room temperature (Fig. S9 in ESI†). In the 19F NMR spectrum a 1
:
8 ratio between the HF signal (δ −174) and the BF4 peak (δ −152) accounts for all the fluorine introduced from the Selectfluor (Fig. S10 in ESI†). On warming to room temperature, decomposition of the palladium intermediate ensued generating biphenyl and 4; full conversion being observed after 48 hours (Fig. S11 in ESI†). Unfortunately, further attempts to fully characterise the high valent palladium intermediate were unsuccessful.
The 1
:
1 reaction of 2,6-diisopropylphenyl-containing 3b with Selectfluor was also explored at a range of different temperatures. However, despite consumption of 3b, there was no evidence for the formation of biphenyl, fluorobenzene nor could any characterisable palladium species be identified. It is unclear as to the origin of these differences in reactivity between 3a and 3b towards Selectfluor.
:
30 mixture of petroleum ether (40–60) and ethyl acetate affording 2-(2-methyl-1,3-dioxolan-2-yl)-6-(2-nitrophenyl)pyridine as a yellow solid (0.517 g, 67%) along with trace amounts of the homocoupled by-product 6,6′-bis(2-methyl-1,3-dioxolan-2-yl)-2,2′-bipyridine. 1H NMR (400 MHz, CDCl3): δ 1.66 (s, 3H, CH3), 3.84 (m, 2H, O–CHH–CHH–O), 4.02 (m, 2H, O–CHH–CHH–O), 2.37 (dd, 3JHH 7.8, 4JHH 1.0, 1H, Ar–H), 7.42–7.46 (m, 1H, Ar–H), 7.50 (dd, 3JHH 7.5, 4JHH 0.9, 1H, Ar–H), 7.54–7.57 (m, 2H, Ar–H), 7.74 (dd, 3JHH 7.8, 3JHH 7.9, Ar–H), 7.78 (dd, 3JHH 8.0, 3JHH 8.1, 1H, Ar–H). 13C {1H} NMR (100 MHz, CDCl3): δ 24.9 (CH3), 65.0 (CH2), 65.1 (CH2), 108.6 (C), 118.7 (CH), 121.7 (CH), 124.4 (CH), 129.1 (CH), 131.1 (CH), 135.3 (C), 137.5 (CH), 149.8 (C), 154.9 (C), 161.1 (C). IR (cm−1): 1587 (C
N)pyridine, 1530 (NO2)asymm, 1369 (NO2)symm HRMS (TOFMS, ASAP): calcd for C15H15N2O4 [M + H]+ 287.1032, found 287.1034.
O), 5.77 (br, s, 2H, NH2), 6.82 (m, 2H, Ar–H), 7.22 (ddd, 3JHH 7.3, 3JHH 8.1, 4JHH 1.6, 1H, Ar–H), 7.56 (dd, 3JHH 7.8, 4JHH 1.5, 1H, Ar–H), 7.85–7.95 (m, 3H, Py–H). 13C{1H} NMR (100 MHz, CDCl3): δ 26.1 (Me–C
O), 117.4, 118.0, 119.0 (CH), 121.3 (C), 125.7 (CH), 129.6 (CH), 130.5 (CH), 137.9 (CH), 146.5 (C), 151.7 (C), 158.7 (C), 199.4 (C
O). IR (cm−1): 3456, 3363 (NH), 1695 (C
O)ketone, 1585 (C
N)pyridine. ESIMS: m/z 213 [M + H]+. HRMS (FAB): calcd for C13H13N2O [M + H]+ 213.10246, found 213.10252.
NAr)C5H3N (HL1)
N), 2.92 (sept, 3JHH 7.0, 1H, CHMe2), 5.79 (br, s, 2H, NH2), 6.76–6.84 (m, 4H, Ar–H), 7.20 (ddd, 3JHH 8.1, 3JHH 7.4, 4JHH 1.5, 1H, Ar–H), 7.23 (d, 3JHH 8.2, 2H, Ar–H), 7.58 (dd, 3JHH 7.8, 3JHH 1.5, 1H, Ar–H), 7.74 (dd, 3JHH 8.0, 4JHH 0.9, 1H, Py–H), 7.86 (dd, 3JHH 7.93, 3JHH 7.9, 1H, Py–H), 8.76 (dd, 3JHH 7.9, 4JHH 1.0, 1H, Py–H). 13C{1H} NMR (100 MHz, CDCl3): δ 16.6 (MeC
N), 24.1 (CHMe2), 33.6 (CHMe2), 117.3, 117.9, 118.8, 119.3 (CH), 122.1 (C), 123.2 (CH), 126.9 (CH), 129.6 (CH), 130.1 (CH), 137.4 (CH), 144.2 (C), 146.5 (C), 148.8 (C), 155.2 (C), 158.2 (C), 166.5 (MeC
N). IR (cm−1): 1635 (C
N)imine, 1587 (C
N)pyridine. ESIMS: m/z 330 [(M + H)]+. HRMS (FAB): calcd C22H24N3 [M + H]+ 330.1970, found 330.1968.
N), 2.75 (sept, 3JHH 6.9, 2H, CHMe2), 5.72 (br, s, 2H, NH2), 6.80 (dd, 3JHH 8.2, 4JHH 1.0, 1H, Ar–H), 6.82 (ddd, 3JHH 8.2, 3JHH 8.2, 4JHH 1.3, 1H, Ar–H), 7.08 (dd, 3JHH 8.7, 3JHH 6.3, 1H, Ar–H), 7.17 (dd, 3JHH 6.9, 3JHH 8.5, 2H, Ar–H), 7.21 (ddd, 3JHH 7.3, 3JHH 8.0, 4JHH 1.5, 1H, Ar–H), 7.59 (dd, 3JHH 8.0, 4JHH 1.5, 1H, Ar–H), 7.78 (dd, 3JHH 8.0, 3JHH 0.9, 1H, Py–H), 7.90 (dd, 3JHH 7.9, 3JHH 7.9, 1H, Py–H), 8.26 (dd, 3JHH 7.8, 4JHH 0.9, 1H, Py–H). 13C{1H} NMR (100 MHz, CDCl3): δ 17.5 (MeC
N), 22.9 (CHMe2), 23.2 (CHMe2), 28.3 (CHMe2), 117.6, 118.2 (CH), 118.8 (C), 122.2 (CH), 123.0 (CH), 123.4 (CH), 123.7 (CH), 129.6 (CH), 130.1 (CH), 135.8 (C), 137.6 (CH), 146.1 (C), 146.3 (C), 154.5 (C), 158.2 (C), 165.0 (Me–C
N). IR (cm−1): 3451, 3282 (br, NH), 1642 (C
N)imine, 1584 (C
N)pyridine. ESIMS: m/z 372 [(M + H)]+. HRMS (FAB): calcd C25H30N3O [M + H]+ 372.24322, found 372.24310.
NAr)}Pd(OAc)] (1)
N), 2.98 (sept, 3JHH 6.9, 1H, CHMe2), 5.60 (br, s, 1H, NH), 6.42 (ddd, 3JHH 6.6, 3JHH 8.5, 4JHH 1.2, 1H, Ar–H), 6.86 (dd, 3JHH 8.5, 4JHH 1.2, 1H, Ar–H), 7.02 (ddd 3JHH 6.6, 3JHH 7.9, 4JHH 1.4, 1H, Ar–H), 7.07 (d, 3JHH 8.4, 2H, Ar–H), 7.23 (d, 3JHH 8.3, 2H, Ar–H), 7.59 (dd, 3JHH 7.4, 4JHH 1.0, 1H, Py–H), 7.89 (d, 3JHH 8.0, 1H, Ar–H), 7.99 (dd, 3JHH 7.4, 3JHH 8.8, 1H, Py–H), 8.56 (d, 3JHH 8.8, 1H, Py–H). 13C{1H} NMR (100 MHz, CDCl3): δ 16.3 (MeC
N), 21.9 (MeCO2), 22.9 (CHMe2), 32.9 (CHMe2), 111.8 (CH), 112.9 (C), 119.7 (CH), 121.5 (CH), 122.0 (CH), 125.4 (CH), 125.6 (CH), 128.3 (CH), 129.1 (CH), 133.5 (CH), 141.7 (C), 146.9 (C), 148.5 (C), 148.8 (C), 152.7 (C), 169.5 (Me–C
N), 177.0 (Me–CO2). IR (cm−1): 1600 (C
N)imine, 1591 (COOasymm/C
Npyridine), 1367 (COO)symm FABMS: m/z 493 [M]+, 433 [M − OAc]+. Anal Calc. for (C24H25N3O2Pd): C, 58.36; H, 5.10; N, 8.51. Found: C, 58.26; H, 5.23; N, 8.51%.
N), 3.14 (sept, 3JHH 6.8, 2H, CHMe2), 6.53 (ddd, 3JHH 8.6, 3JHH 6.5, 4JHH 1.4, 1H, Ar–H), 7.06 (dd, 3JHH 8.5, 4JHH 1.2, 1H, Ar–H), 7.13 (ddd, 3JHH 8.5, 3JHH 6.4, 4JHH 1.4, 1H, Ar–H), 7.26 (m, 2H, Ar–H), 7.36 (dd, 3JHH 8.7, 3JHH 6.8, 1H, Ar–H), 7.39 (br, s, 1H, NH), 7.82 (dd 3JHH 7.4, 4JHH 1.0, 1H, Py–H), 8.01 (d, 3JHH 8.6, 1H, Ar–H), 8.10 (dd, 3JHH 8.8, 3JHH 7.3, 1H, Py–H), 6.80 (d, 3JHH 8.7, 1H, Py–H). 13C{1H} NMR (100 MHz, CDCl3): δ 17.0 (CHMe2), 22.3 (CHMe2), 22.7 (MeCO2), 22.8 (MeC
N), 27.6 (CHMe2), 112.0 (CH), 112.6 (C), 120.3 (CH), 121.0 (CH), 122.4 (CH), 125.7 (CH), 126.7 (CH), 127.7 (CH), 129.2 (CH), 132.5 (CH), 139.0 (C), 139.4 (C), 149.0 (C), 149.2 (C), 152.7 (C), 170.1 (Me–C
N), 177.2 (Me–CO2). IR (cm−1): 1614 (C
N)imine, 1583 (COO)asymm/C
Npyridine), 1367 (COO)symm ESIMS: m/z 476 [M − OAc]+. TOFMS (ASAP): m/z 536 [M+], 476 [M − OAc]+. Anal Calc. for (C28H32Cl3N3O2Pd): C, 51.32; H, 4.92; N, 6.41. Found: C, 50.92; H, 4.18; N, 7.36%.
NAr)}PdCl] (2)
N), 2.89 (sept, 3JHH 6.9, 1H, CHMe2), 5.59 (br, s, 1H, NH), 6.43 (ddd, 3JHH 6.1, 3JHH 8.0, 4JHH 1.20, 1H, Ar–H), 6.81 (dd, 3JHH 8.6, 4JHH 1.0, 1H, Ar–H), 6.99–7.03 (m, 5H, Ar–H), 7.19 (d, 3JHH 8.2, 2H, Ar–H), 7.55 (dd, 3JHH 7.5, 4JHH 0.9, 1H, Py–H), 7.73–7.79 (m, 2H, Py–H/Ar–H), 8.30 (d, 3JHH 8.7, 1H, Py–H). 13C {1H} NMR (125 MHz, CDCl3): δ 17.0 (CH3C
N), 22.9 (CHMe2), 32.7 (CHMe2), 112.1 (CH), 112.8 (C), 119.7 (CH), 121.6 (CH), 122.3 (CH), 125.1 (CH), 125.5 (CH), 128.2 (CH), 129.5 (CH), 133.4 (CH), 142.9 (C), 146.6 (C), 148.4 (C), 148.4 (C), 153.1 (C), 171.0 (Me–C
N). IR (cm−1): 1603 (C
N)imine, 1576 (C
N)pyridine. FABMS: m/z 469 (M)+, 434 (M–Cl)+. Anal Calc. for (For C22H22ClN3Pd): C, 56.18; H, 4.71; N, 8.93. Found: C, 56.11; H, 4.69; N, 9.00%.
N), 2.99 (sept, 3JHH 6.9, 2H, CHMe2), 5.91 (br, s, 1H, NH), 6.49 (ddd, 3JHH 8.5, 3JHH 6.7, 4JHH 1.3, 1H, Ar–H), 6.92 (dd, 3JHH 8.6, 4JHH 1.2, 1H, Ar–H), 7.06 (ddd, 3JHH 8.2, 3JHH 6.5, 4JHH 1.4, Ar–H), 7.19 (m, 2H, Ar–H), 7.28 (dd, 3JHH 8.5, 3JHH 8.5, 1H, Ar–H), 7.77 (dd, 3JHH 7.3, 4JHH 1.1, 1H, Py–H), 7.92 (dd, 3JHH 8.6, 4JHH 1.5, 1H, Ar–H), 8.06 (dd, 3JHH 8.8, 3JHH 8.4, 1H, Py–H), 8.63 (d, 3JHH 8.6, 1H, Py–H). 13C {1H} NMR (125 MHz, CDCl3): δ 18.0 (Me–C
N), 23.7 (CHMe2), 23.8 (CHMe2), 28.7 (CHMe2), 113.6 (CH), 113.8 (C), 121.3 (CH), 122.1 (CH), 123.6 (CH), 127.2 (CH), 128.1 (CH), 129.1 (CH), 130.8 (CH), 134.1 (CH), 139.7 (C), 141.6 (C), 150.0 (C), 150.3 (C), 153.7 (C), 172.1 (Me–C
N). IR (cm−1): 1608 (C
N)imine, 1577 (C
N)pyridine. FABMS: m/z 511 [M + H]+, 475 [M − Cl]+. Anal Calc. for (C25H28ClN3Pd): C, 58.60; H, 5.51; N, 8.20. Found: C, 58.49; H, 5.35; N, 8.26%.
NAr)}Pd(C6H5)] (3)
N), 2.80 (sept, 3JHH 6.9, 1H, CHMe2), 5.48 (br, s, 1H, NH), 6.44 (ddd, 3JHH 6.5, 3JHH 8.0, 4JHH 1.1, 1H, Ar–H), 6.65 (d, 3JHH 8.4, 2H, Ar–H), 6.73–6.75 (m, 3H, Ar–H), 6.90 (dd, 3JHH 8.6, 4JHH 1.3, 1H, Ar–H), 6.95 (d, 3JHH 8.4, 2H, Ar–H), 7.05 (ddd, 3JHH 6.6, 3JHH 8.1, 4JHH 1.4, 1H, Ar–H), 7.07–7.09 (m, 2H, Ar–H), 7.82 (d, 3JHH 7.1, 1H, Py–H), 7.98 (dd, 3JHH 8.5, 4JHH 1.3, 1H, Ar–H), 8.05 (dd, 3JHH 7.5, 3JHH 8.6, 1H, Py–H), 8.58 (d, 3JHH 8.8, 1H, Py–H). 13C{1H} NMR (100 MHz, CDCl3) δ 18.3 (Me–C
N), 24.0 (CHMe2), 33.7 (CHMe2), 111.9 (CH), 114.0 (C), 121.3 (CH), 122.2 (CH), 122.6 (CH), 122.9 (CH), 125.9 (CH), 126.0 (CH), 126.1 (CH), 129.9 (CH), 130.0 (CH), 134.2 (CH), 135.9 (CH), 145.1, 146.9, 152.0, 152.1, 153.1, 158.5 (C), 170.5 (MeC
N). IR (cm−1): 1602 (C
N)imine, 1567 (C
N)pyridine. FABMS: m/z 511 [M]+. Anal Calc. for (C28H27N3Pd·1.5OH2): C, 62.40; H, 5.61; N, 7.80. Found: C, 62.04; H, 5.33; N, 8.16%.
N), 2.94 (sept, 3JHH 6.8, 2H, CHMe2), 6.40 (ddd, 3JHH 8.1, 3JHH 6.6, 4JHH 1.3, 1H, Ar–H), 6.66–6.73 (m, 3H, Ar–H), 6.84 (dd, 3JHH 8.4, 4JHH 1.2, 1H, Ar–H), 6.88–6.93 (m, 2H, Ar–H), 6.99 (ddd, 3JHH 8.3, 3JHH 6.6, 4JHH 1.6, 1H, Ar–H), 6.99 (d, 3JHH 7.8, 2H, Ar–H), 7.12 (dd, 3JHH 7.7, 3JHH 7.7, 1H, Ar–H), 7.80 (dd, 3JHH 7.5, 4JHH 1.0, 1H, PyH), 7.91 (dd, 3JHH 8.6, 4JHH 1.4, 1H, Ar–H), 8.02 (dd, 3JHH 8.8, 3JHH 7.5, 1H, Py–H), 8.55 (d, 3JHH 8.7, 1H, Py–H). 13C{1H} NMR (100 MHz, CDCl3): δ 19.3 (MeC
N), 22.9 (CHMe2), 24.2 (CHMe2), 28.2 (CHMe2), 112.1 (CH), 114.5 (C), 121.3 (C), 122.5 (CH), 122.8 (CH), 123.5 (CH), 125.8 (CH), 126.5 (CH), 127.1 (CH), 130.0 (CH), 130.1 (CH), 134.3 (CH), 135.9 (CH), 139.5 (CH), 142.9 (C), 151.5 (C), 152.4 (C), 153.2 (C), 155.5 (C), 172.1 (Me–C
N). IR (cm−1): 1605 (C
N)imine, 1571 (C
N)pyridine. FABMS: m/z 553 [M + H]+.
N(4-i-PrC6H4)}Pd(NCMe)][X] (4 and 5)
N), 2.93 (sept, 3JHH 6.9, 1H, CHMe2), 6.60 (dd, 3JHH 7.5, 3JHH 7.5, 1H, Ar–H), 6.98 (d, 3JHH 8.4, 1H, Ar–H), 7.04 (d, 3JHH 7.8, 2H, Ar–H), 7.10 (dd, 3JHH 7.6, 3JHH 7.8, 1H, Ar–H), 7.34 (d, 3JHH 8.0, 2H, Ar–H), 7.83 (d, 3JHH 7.5, 1H, Py–H), 7.89 (d, 3JHH 8.0, 1H, Ar–H), 8.08 (dd, 3JHH 8.0, 3JHH 8.0, 1H, Py–H), 8.53 (d, 3JHH 8.6, 1H, Py–H), the coordinated CH3CN ligand was not observed due to rapid exchange with bulk CD3CN. 13C{1H} NMR (100 MHz, CD3CN): δ 17.0 (CH3C
N), 22.9 (CHMe2), 33.3 (CHMe2), 115.3 (CH), 117.0 (C), 119.6 (CH), 122.3 (CH), 124.9 (CH), 126.9 (CH), 127.0 (CH), 129.7 (CH), 131.2 (CH), 136.8 (CH), 142.9 (C), 147.1 (C), 148.8 (C), 149.5 (C), 155.0 (C), 174.8 (C
N). 19F{1H} NMR (375 MHz, CD3CN): δ −151 (-BF4). ESIMS (+ve) m/z: 475 [M − BF4]+; ESIMS (−ve): m/z 87 [BF4]−. Anal Calc. for (C24H25N4F4PdB): C, 51.23; H, 4.48; N, 9.96. Found: C, 51.13; H, 4.40; N, 9.87%.
:
95) gave 5 as a microcrystalline powder. Single crystals of pyridine-containing 5′ suitable for X-ray diffraction could be obtained by slow diffusion of hexane into a chloroform solution of 5 that contained a few drops of pyridine. Complex 5: Mp: >260 °C. 1H NMR (400 MHz, CD3CN): δ 1.32 (d, 3JHH 6.9, 6H, CHMe2), 2.51 (s, 3H, MeC
N), 3.05 (sept, 3JHH 6.9, 1H, CHMe2), 6.14 (br, s, 1H, NH), 6.74 (app. t, 3JHH 7.7, 1H, Ar–H), 7.17–7.23 (m, 3H, Ar–H), 7.26–7.29 (m, 1H, Ar–H), 7.48 (d, 3JHH 8.3, 2H, Ar–H), 8.16 (m, 2H, Ar–H), 8.33 (dd, 3JHH, 8.0, 3JHH 8.0, 1H, Py–H), 8.54 (d, 3JHH 8.5, 1H, Py–H), the coordinated CH3CN ligand was not observed due to rapid exchange with bulk CD3CN. 13C{1H} NMR (100 MHz, CD3CN): δ 17.0 (MeC
N), 22.9 (CHMe2), 33.3 (CHMe2), 115.4 (CH), 119.2 (C), 119.7 (CH), 122.4 (CH), 124.9 (CH), 126.9 (CH), 129.7 (CH), 131.0 (CH), 136.7 (CH), 142.8 (C), 146.7 (C), 148.8 (C), 149.3 (C), 154.8 (C), 174.7 (MeC
N), CF3SO3− not observed. 19F{1H} NMR (375 MHz, CD3CN): δ −79 (O3SCF3). IR (cm−1): 1602 (C
N)imine, 1570 (C
N)pyridine. ESIMS (+ve): m/z 475 [M − O3SCF3]+; ESIMS (−ve): m/z: 149 [O3SCF3]−. Anal Calc. for (C25H25N4O3F3PdS·CH2Cl2): C, 43.99; H, 3.83; N, 7.89. Found: C, 44.13; H, 3.78; N, 7.60%.
N), 2.82 (sept, 3JHH 6.8, 1H, CHMe2), 6.70 (d, 3JHH, 8.5, 2H, Ar–H), 6.72–6.77 (m, 2H, Ar–H), 6.84–6.86 (m, 2H, Ar–H), 7.04 (d, 3JHH 8.4, 2H, Ar–H), 7.36–7.43 (m, 2H, Ar–H), 7.47–7.55 (m, 2H, Ar–H), 7.86 (dd, 3JHH 7.7, 4JHH 1.9, 1H, Ar–H), 8.17 (m, 1H, Ar–H), 8.40 (m, 2H, Ar–H). 19F{1H} NMR (375 MHz, CD3CN): δ −152 (BF4), −172 (HF). At −30 °C, 1H NMR δ no change. 19F{1H} NMR: δ −152 (BF4), −172 (HF). At −20 °C, 1H NMR δ no change. 19F{1H} NMR: δ −152 (BF4), −173 (HF). At −10 °C, 1H NMR δ no change. 19F{1H} NMR: δ −152 (BF4), −173 (HF). At 0 °C: 1H NMR δ no change. 19F{1H} NMR: δ −152 (8F, BF4), −174 (1F, HF).
| Complex | HL1b | 1a | 1b | 2a |
|---|---|---|---|---|
| Formula | C25H29N3 | C24H25Cl3N3O2Pd·CHCl3·OH2 | C28H32Cl3N3O2Pd | C22H22ClN3Pd |
| M | 371.51 | 631.25 | 655.32 | 470.28 |
| Crystal size (mm3) | 0.24 × 0.17 × 0.12 | 0.27 × 0.05 × 0.04 | 0.27 × 0.17 × 0.11 | 0.23 × 0.20 × 0.04 |
| Temperature (K) | 150(2) | 150(2) | 150(2) | 150(2) |
| Crystal system | Orthorhombic | Triclinic | Triclinic | Monoclinic |
| Space group | Pbca |
P![]() |
P![]() |
P2(1)/n |
| a (Å) | 12.906(10) | 6.9770(16) | 14.194(4) | 17.674(4) |
| b (Å) | 8.308(6) | 12.184(3) | 15.316(4) | 8.9111(19) |
| c (Å) | 39.43(3) | 15.543(4) | 15.711(4) | 24.267(5) |
| α (°) | 90 | 87.923(4) | 61.002(5) | 90 |
| β (°) | 90 | 84.029(5) | 77.050(7) | 93.133(5) |
| γ (°) | 90 | 84.203(5) | 80.162(7) | 90 |
| U (Å3) | 4228(5) | 1307.0(5) | 2903.6(14) | 3816.2(14) |
| Z | 8 | 2 | 4 | 8 |
| D c (Mg m−3) | 1.167 | 1.604 | 1.499 | 1.637 |
| F(000) | 1600 | 640 | 1336 | 1904 |
| μ(Mo-Kα)(mm−1) | 0.069 | 1.049 | 0.945 | 1.124 |
| Reflections collected | 28 600 |
10 332 |
22 854 |
28 912 |
| Independent reflections | 3715 | 5074 | 11 293 |
7469 |
| R int | 0.2201 | 0.1059 | 0.1479 | 0.1336 |
| Restraints/parameters | 0/258 | 20/319 | 0/679 | 1/493 |
| Final R indices (I > 2σ(I)) | R 1 = 0.0628 | R 1 = 0.0683 | R 1 = 0.0873 | R 1 = 0.0582 |
| wR2 = 0.1155 | wR2 = 0.1067 | wR2 = 0.1788 | wR2 = 0.0914 | |
| All data | R 1 = 0.1397 | R 1 = 0.1235 | R 1 = 0.1888 | R 1 = 0.1237 |
| wR2 = 0.1377 | wR2 = 0.1232 | wR2 = 0.2173 | wR2 = 0.1078 | |
| Goodness of fit on F2 (all data) | 0.871 | 0.861 | 0.848 | 0.890 |
| Complex | 2b | 3a | 3b | 5′ |
|---|---|---|---|---|
| a Data in common: graphite-monochromated Mo-Kα radiation, λ = 0.71073 Å; R1 = ∑||Fo| − |Fc||/∑|Fo|, wR2 = [∑w(Fo2 − Fc2)2/∑w(Fo2)2]1/2, w−1 = [σ2(Fo)2 + (aP)2], P = [max(Fo2, 0) + 2(Fc2)]/3, where a is a constant adjusted by the program; goodness of fit = [∑(Fo2 − Fc2)2/(n − p)]1/2 where n is the number of reflections and p the number of parameters. | ||||
| Formula | C26H29Cl4N3Pd | C28H27N3Pd | C31H33N3Pd | C28H26F3N4 O3PdS·2CHCl3 |
| M | 631.72 | 511.93 | 554.00 | 900.72 |
| Crystal size (mm3) | 0.36 × 0.31 × 0.04 | 0.26 × 0.12 × 0.05 | 0.25 × 0.22 × 0.10 | 0.46 × 0.14 × 0.04 |
| Temperature (K) | 150(2) | 150(2) | 150(2) | 150(2) |
| Crystal system | Monoclinic | Monoclinic | Orthorhombic | Triclinic |
| Space group | P2(1)/n | P2(1)/c | Pbca |
P![]() |
| a (Å) | 11.410(8) | 17.244(11) | 12.118(3) | 14.155(7) |
| b (Å) | 17.663(13) | 11.142(8) | 10.844(3) | 16.226(8) |
| c (Å) | 12.991(9) | 12.238(8) | 40.250(10) | 17.503(8) |
| α (°) | 90 | 90 | 90 | 89.109(9) |
| β (°) | 94.182(13) | 105.925(14) | 90 | 76.364(11) |
| γ (°) | 90 | 90 | 90 | 70.267(10) |
| U (Å3) | 2611(3) | 2261(3) | 5289(2) | 3668(3) |
| Z | 4 | 4 | 8 | 4 |
| D c (Mg m−3) | 1.607 | 1.504 | 1.391 | 1.631 |
| F(000) | 1280 | 1048 | 2288 | 1804 |
| μ(Mo-Kα)(mm−1) | 1.141 | 0.842 | 1.391 | 1.053 |
| Reflections collected | 19 939 |
17 292 |
41 613 |
26 756 |
| Independent reflections | 5116 | 4444 | 5763 | 12 826 |
| R int | 0.0775 | 0.2311 | 0.0699 | 0.2649 |
| Restraints/parameters | 0/312 | 0/292 | 0/321 | 749/889 |
| Final R indices (I > 2σ(I)) | R 1 = 0.0446 | R 1 = 0.0732 | R 1 = 0.0431 | R 1 = 0.1055 |
| wR2 = 0.0904 | wR2 = 0.1210 | wR2 = 0.0906 | wR2 = 0.2112 | |
| All data | R 1 = 0.0615 | R 1 = 0.1615 | R 1 = 0.0569 | R 1 = 0.2711 |
| wR2 = 0.0955 | wR2 = 0.1450 | wR2 = 0.0955 | wR2 = 0.2821 | |
| Goodness of fit on F2 (all data) | 1.044 | 0.867 | 1.122 | 0.829 |
Footnote |
| † Electronic supplementary information (ESI) available. CCDC 1043191–1043198. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c5dt00216h |
| This journal is © The Royal Society of Chemistry 2015 |